Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.
BACKGROUND
Antibody to hepatitis E virus (anti-HEV) is prevalent in Western countries, where clinical hepatitis E is rarely reported. The aim of this study was to determine the prevalence of anti-HEV among Danish blood donors and Danish farmers. In addition, we compared the prevalence among 2 sets of serum samples obtained from blood donors 20 years apart.


METHODS
Samples from 291 Danish farmers and 169 blood donors that were collected in 1983 and samples from 461 blood donors that were collected in 2003 were tested for anti-HEV. Relevant information on HEV exposure was collected by self-administered questionnaire.


RESULTS
Anti-HEV testing was performed on samples after 20 years of storage at -20 degrees C. The prevalence of anti-HEV was 50.4% among farmers and 32.9% among donors in 1983 and 20.6% among donors in 2003 (P < .05). Presence of anti-HEV was significantly correlated with increasing age in all 3 groups (P < .05). Among donors who had serum samples obtained in 2003, age, contact with horses, and the presence of antibody to hepatitis A virus were associated with the presence of anti-HEV in multivariate analysis. Among farmers, only age was independently associated with the presence of anti-HEV.


CONCLUSIONS
Anti-HEV was highly prevalent among Danes but has decreased in prevalence over the past 50 years. Our study supports the hypothesis that HEV infection in Denmark may be an asymptomatic zoonotic infection.
Christensen
Peer B
PB
Department of Infectious Diseases, Odense University Hospital, Denmark. peer.christensen@dadlnet.dk
Engle
Ronald E
RE
Hjort
Charlotte
C
Homburg
Keld M
KM
Vach
Werner
W
Georgsen
Jørgen
J
Purcell
Robert H
RH
D000328:Adult; D000367:Age Factors; D000383:Agriculture; D000818:Animals; D001782:Blood Donors; D003718:Denmark / Q000453:epidemiology; D006508:Hepatitis Antibodies / Q000097:blood*; D016751:Hepatitis E / Q000453:epidemiology*; D006801:Humans; D008875:Middle Aged; D015999:Multivariate Analysis; D016036:Seroepidemiologic Studies; D013223:Statistics as Topic; D011795:Surveys and Questionnaires; D013997:Time Factors; D015047:Zoonoses / Q000453:epidemiology*
D006508:Hepatitis Antibodies
J Virol. 1998 Dec;72(12):9714-21
9811705
J Infect Dis. 2003 Sep 15;188(6):944
12964128
Infection. 1998 Nov-Dec;26(6):409
9861572
N Engl J Med. 1987 Apr 16;316(16):965-70
2436048
Ugeskr Laeger. 1981 Nov 30;143(49):3301-3
6277064
N Engl J Med. 2008 Feb 21;358(8):811-7
18287603
J Infect Dis. 2005 Oct 1;192(7):1166-72
16136458
Lancet. 2003 Aug 2;362(9381):371-3
12907011
J Clin Microbiol. 1997 May;35(5):1244-7
9114415
J Clin Microbiol. 2002 Dec;40(12):4576-80
12454155
J Med Virol. 2004 Nov;74(3):419-24
15368508
Infect Genet Evol. 2007 Jun;7(3):368-73
17046335
Scand J Infect Dis. 2005;37(2):127-30
15773034
Scand J Infect Dis. 2006;38(1):55-8
16338839
Virology. 2004 Dec 20;330(2):501-5
15567444
J Med Virol. 1999 Apr;57(4):356-60
10089046
J Med Virol. 1999 Nov;59(3):297-302
10502259
Curr Opin Infect Dis. 2006 Oct;19(5):460-6
16940870
J Infect Dis. 1993 Aug;168(2):369-78
8335973
BMC Infect Dis. 2008 May 08;8:61
18462508
J Viral Hepat. 2005 Jul;12(4):439-42
15985017
J Med Virol. 2002 Jan;66(1):49-55
11748658
J Gen Virol. 2006 Jan;87(Pt 1):217-223
16361434
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9860-5
9275216
Allergy. 1986 Feb;41(2):104-9
3085531
J Food Prot. 2007 Dec;70(12):2889-95
18095450
J Infect Dis. 1995 Feb;171(2):447-50
7844387
Clin Infect Dis. 2000 Mar;30(3):618-9
10722465
J Infect Dis. 2001 Dec 15;184(12):1594-7
11740735
J Med Virol. 1998 Jun;55(2):134-7
9598934
N Engl J Med. 2007 Mar 1;356(9):895-903
17329696
J Infect Dis. 1997 Jul;176(1):34-40
9207347
N Engl J Med. 1998 Nov 19;339(21):1554-5
9841331
J Hepatol. 2008 Mar;48(3):494-503
18192058
Scand J Infect Dis. 1997;29(2):99-102
9181642
Hepatology. 1998 Mar;27(3):857-61
9500718
J Clin Microbiol. 2002 Jan;40(1):117-22
11773103
J Gen Virol. 1999 Mar;80 ( Pt 3):681-690
10092008
J Gen Virol. 2007 Mar;88(Pt 3):912-917
17325364